Genetics, Cell Biology, and Pathophysiology of Pancreatitis
Mayerle, J., Sendler, M., Hegyi, E., Beyer, G., Lerch, M. M., and Sahin-Toth, M. (2019). Gastroenterology 156, 1951-1968 e1951. doi: 10.1053/j.gastro.2018.11.081
Abstract:
The clinical course of an episode of
acute pancreatitis varies from a mild, transitory form to a severe necrotizing form characterized by multisystem organ failure and mortality in 20% to 40% of cases. Mild
pancreatitis does not need specialized
treatment, and surgery is necessary only to treat underlying mechanical factors such as gallstones or tumours at the papilla of Vater. On the other hand, patients with severe necrotizing
pancreatitis need to be identified as
early as possible after the onset of symptoms to start intensive care
treatment. In this subgroup of patients, approximately 15% to 20% of all patients with
acute pancreatitis,
stratification according to infection status is crucial. Patients with infected necrosis must undergo surgical intervention, which consists of an organ-preserving necrosectomy followed by postoperative lavage and/or drainage to evacuate necrotic debris, which appears during the further course of the condition. Primary intensive care
treatment, including antibiotic
treatment, delays the need for surgery in most patients until the third or fourth week after the onset of symptoms. At that time, necrosectomy is technically easier to perform and the bleeding
risk is reduced, compared with necrosectomy earlier in the disease course. In patients with sterile necrosis, the available data strongly support a
conservative approach (ie, intensive care unit
treatment). Surgery is rarely necessary in these patients.